Humana Inc. (NYSE:HUM) Shares Sold by Sigma Planning Corp

Sigma Planning Corp trimmed its position in Humana Inc. (NYSE:HUM) by 65.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 656 shares of the insurance provider’s stock after selling 1,255 shares during the period. Sigma Planning Corp’s holdings in Humana were worth $208,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. lifted its stake in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after buying an additional 39 shares in the last quarter. Creative Financial Designs Inc. ADV raised its stake in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. Atwood & Palmer Inc. acquired a new stake in Humana during the 3rd quarter worth $29,000. Hantz Financial Services Inc. acquired a new stake in shares of Humana in the second quarter valued at about $35,000. Finally, Family Firm Inc. purchased a new stake in Humana during the 2nd quarter valued at about $37,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on HUM shares. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a research note on Tuesday, October 8th. Piper Sandler cut shares of Humana from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $392.00 to $274.00 in a research report on Thursday, October 3rd. JPMorgan Chase & Co. boosted their target price on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Truist Financial dropped their price target on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research note on Friday, October 11th. Finally, Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and lifted their price target for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $315.86.

Humana Stock Down 2.6 %

Shares of NYSE:HUM opened at $275.67 on Monday. The company has a 50 day moving average of $281.36 and a 200-day moving average of $331.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The stock has a market cap of $33.19 billion, a price-to-earnings ratio of 24.42, a P/E/G ratio of 2.17 and a beta of 0.52.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, sell-side analysts forecast that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.28%. Humana’s payout ratio is 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.